Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis Barbara WillekensNathalie Cools Leading Article Open access 14 May 2018 Pages: 401 - 410
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review P. MoleroJ. A. Ramos-QuirogaJ. J. Meana Review Article 07 May 2018 Pages: 411 - 420
Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review MacKenzie R. PeltierMehmet Sofuoglu Review Article 14 May 2018 Pages: 421 - 435
Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial Harmen BeurmanjerRama M. KamalArnt F. A. Schellekens short communication Open access 12 April 2018 Pages: 437 - 442
ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability Yuval RamotAbraham NyskaOron Yacobi-Zeevi Original Research Article 10 April 2018 Pages: 443 - 454
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Tobias BanaschewskiMats JohnsonDavid R. Coghill Original Research Article Open access 23 May 2018 Pages: 455 - 467
Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010 Simon FaissnerRalf Gold Correction 24 May 2018 Pages: 469 - 471
Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy Sheridan M. Hoy Adis Drug Evaluation 21 May 2018 Pages: 473 - 484
